<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34567890</PMID><DateRevised><Year>2021</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Multiple Primary Malignancies in Head and Neck Cancer: A University Hospital Experience Over a Five-Year Period.</ArticleTitle><Pagination><StartPage>e17349</StartPage><MedlinePgn>e17349</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e17349</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.17349</ELocationID><Abstract><AbstractText>Introduction With an estimated incidence of 2%-4% per year, the development of a second primary malignancy (SPM) in patients with head and neck tumors (HNTs) is not a rare event. The present study aimed to (i) assess the frequency of SPMs in patients with HNTs treated in a university hospital over a five-year period and (ii) provide a demographic characterization of these patients. Methods Retrospective single-centre study of patients with more than one primary tumor (including at least one HNT) diagnosed between January 1, 2015, and December 31, 2019. Data were retrieved from patients' clinical records and anonymized for analysis purposes. Results A total of 53 out of 824 (6.43%) patients with multiple primary malignancies were identified, 18 of which synchronous and 35 metachronous. The median follow-up was 25 months. Thirteen patients were diagnosed with more than one HNT. Forty patients were diagnosed with at least one HNT and one non-HNT. The most frequently diagnosed non-HNT SPMs were lung cancer (n=17) and esophageal cancer (n=8). The five-year survival rate was 53% for patients with multiple HNSCCs and 47% for patients with at least one non-HNT (log-rank p=0.729).&#xa0;The median overall survival was 14 months for synchronous and 58 months for metachronous SPMs (log-rank p=0.002). Conclusion Findings from this study highlight the importance of long-term follow-up of HNT patients for early detection of SPMs, increasing the chance of providing treatment with curative intent and improving patient outcomes and survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021, Batista et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batista</LastName><ForeName>Marta Vaz</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Medical Oncology, Hospital Prof. Doutor Fernando Fonseca, Lisboa, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulrich</LastName><ForeName>Jo&#xe3;o</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Radiotherapy, Centro Hospitalar Universit&#xe1;rio de Lisboa Norte, Lisboa, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Oncology, Centro Hospitalar Universit&#xe1;rio de Lisboa Norte, Lisboa, PRT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Leonor Abreu</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Medical Oncology, Centro Hospitalar Universit&#xe1;rio de Lisboa Norte, Lisboa, PRT.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">field cancerization</Keyword><Keyword MajorTopicYN="N">head and neck cancer</Keyword><Keyword MajorTopicYN="N">head and neck neoplasms</Keyword><Keyword MajorTopicYN="N">multiple primary malignancies</Keyword><Keyword MajorTopicYN="N">second primary malignancy&#xa0;</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34567890</ArticleId><ArticleId IdType="pmc">PMC8454462</ArticleId><ArticleId IdType="doi">10.7759/cureus.17349</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. CA Cancer J Clin. 2020;68:394&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Head and neck cancer. Chow LQ. N Engl J Med. 2020;382:60&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">31893516</ArticleId></ArticleIdList></Reference><Reference><Citation>Histopathological variants of oral squamous cell carcinoma-institutional case reports. Pathak J, Swain N, Patel S, Poonja L. J Oral Maxillofac Pathol. 2014;18:143&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065435</ArticleId><ArticleId IdType="pubmed">24959057</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple primary malignant tumors. A survey of the literature and a statistical study. Warren S, Gates O. https://ci.nii.ac.jp/naid/10005037946/ Am J Cancer. 1932;16:1358&#x2013;1414.</Citation></Reference><Reference><Citation>Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Slaughter SP, Southwick HW, Smejkal W. https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/1097-0142(195309)6:5%3C963::AID-CNCR2820060515%3E3.0.CO;2-Q. Cancer. 1953;6:963&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pubmed">13094644</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Van Der Wal JE, Snow GB, Leemans CR, Braakhuis BJ. Am J Pathol. 2002;161:1051&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1867244</ArticleId><ArticleId IdType="pubmed">12213734</ArticleId></ArticleIdList></Reference><Reference><Citation>Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Machiels JP, Ren&#xe9; Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V. Ann Oncol. 2020;31:1462&#x2013;1475.</Citation><ArticleIdList><ArticleId IdType="pubmed">33239190</ArticleId></ArticleIdList></Reference><Reference><Citation>National Comprehensive Cancer Network. Head and Neck Cancers (version 2.2021)  [May;2021 ];https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf 2021 </Citation></Reference><Reference><Citation>Risk of onset of second neoplasms and successive neoplasms in patients with a head and neck index tumour. Le&#xf3;n X, Garc&#xed;a J, L&#xf3;pez M, Rodrigues C, Gutierrez A, Quer M. Acta Otorrinolaringol Esp. 2020;71:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">30987756</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. Ng SP, Pollard C 3rd, Kamal M, et al. NPJ Precis Oncol. 2019;3:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6764977</ArticleId><ArticleId IdType="pubmed">31583278</ArticleId></ArticleIdList></Reference><Reference><Citation>Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Kim SY, Roh JL, Yeo NK, Kim JS, Lee JH, Choi SH, Nam SY. Ann Oncol. 2007;18:1698&#x2013;1703.</Citation><ArticleIdList><ArticleId IdType="pubmed">17716985</ArticleId></ArticleIdList></Reference><Reference><Citation>Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. Le&#xf3;n X, Del Prado Venegas M, Or&#xfa;s C, Kola&#xf1;czak K, Garc&#xed;a J, Quer M. Eur Arch Otorhinolaryngol. 2005;262:905&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">15891925</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Chuang SC, Scelo G, Tonita JM, et al. Int J Cancer. 2008;123:2390&#x2013;2396.</Citation><ArticleIdList><ArticleId IdType="pubmed">18729183</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. J&#xe9;gu J, Binder-Foucard F, Borel C, Velten M. Oral Oncol. 2013;49:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">22840787</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of head and neck cancer. Rothman KJ. Laryngoscope. 1978;88:435&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">628297</ArticleId></ArticleIdList></Reference><Reference><Citation>Second primary tumors in patients with head and neck cancer. Priante AV, Castilho EC, Kowalski LP. Curr Oncol Rep. 2011;13:132&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">21234721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>
